{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:48:50Z","timestamp":1759146530148,"version":"3.40.3"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126720","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T13:28:04Z","timestamp":1736774884000},"page":"126720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Functional characterization of MMAR_1296 in Mycobacterium marinum and its potential as a vaccine candidate"],"prefix":"10.1016","volume":"48","author":[{"given":"Weile","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2025.126720_bb0005","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1462-5822.2008.01133.x","article-title":"Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis","volume":"10","author":"Tobin","year":"2008","journal-title":"Cell Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126720_bb0010","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1101\/gr.075069.107","article-title":"Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis","volume":"18","author":"Stinear","year":"2008","journal-title":"Genome Res"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126720_bb0015","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.4049\/jimmunol.181.10.7166","article-title":"The ESX-5 secretion system of Mycobacterium marinum modulates the macrophage response","volume":"181","author":"Abdallah","year":"2008","journal-title":"J Immunol"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2025.126720_bb0020","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1099\/mic.0.2008\/019968-0","article-title":"A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins","volume":"154","author":"Singh","year":"2008","journal-title":"Microbiology (Reading)"},{"issue":"6685","key":"10.1016\/j.vaccine.2025.126720_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.126720_bb0030","doi-asserted-by":"crossref","unstructured":"F. De Maio, R. Berisio, R. Manganelli, and G. Delogu, \u201cPE_PGRS proteins of Mycobacterium tuberculosis: A specialized molecular task force at the forefront of host\u2013pathogen interaction,\u201d Virulence, vol. 11, no. 1, pp. 898\u2013915, doi:https:\/\/doi.org\/10.1080\/21505594.2020.1785815.","DOI":"10.1080\/21505594.2020.1785815"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126720_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01951-19","article-title":"Type VII secretion substrates of pathogenic mycobacteria are processed by a surface protease","volume":"10","author":"Burggraaf","year":"2019","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126720_bb0040","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/IAI.71.3.1379-1388.2003","article-title":"Isolation of acid-inducible genes of Mycobacterium tuberculosis with the use of recombinase-based in vivo expression technology","volume":"71","author":"Saviola","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126720_bb0045","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1128\/JB.188.10.3721-3725.2006","article-title":"Variable expression patterns of Mycobacterium tuberculosis PE_PGRS genes: evidence that PE_PGRS16 and PE_PGRS26 are inversely regulated in vivo","volume":"188","author":"Dheenadhayalan","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2025.126720_bb0050","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1038\/s41467-022-31333-0","article-title":"A glycine-rich PE_PGRS protein governs mycobacterial actin-based motility","volume":"13","author":"Hill","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126720_bb0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micinf.2005.06.021","article-title":"Expression of the PE_PGRS 33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival","volume":"8","author":"Dheenadhayalan","year":"2006","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126720_bb0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tube.2011.04.004","article-title":"The PE and PPE proteins of Mycobacterium tuberculosis","volume":"91","author":"Mukhopadhyay","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2025.126720_bb0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1099\/jmm.0.026047-0","article-title":"Expression of the Mycobacterium tuberculosis PPE37 protein in Mycobacterium smegmatis induces low tumour necrosis factor alpha and interleukin 6 production in murine macrophages","volume":"60","author":"Daim","year":"2011","journal-title":"J Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126720_bb0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2958.2006.05409.x","article-title":"A specific secretion system mediates PPE41 transport in pathogenic mycobacteria","volume":"62","author":"Abdallah","year":"2006","journal-title":"Mol Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126720_bb0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2958.2004.04007.x","article-title":"Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure","volume":"52","author":"Delogu","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2025.126720_bb0080","article-title":"Mycobacterium tuberculosis PE_PGRS41 enhances the intracellular survival of M. Smegmatis within macrophages Via blocking innate immunity and inhibition of host defense","volume":"7","author":"Deng","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00549-21","article-title":"Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with Rab1A","volume":"6","author":"Strong","year":"2021","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126720_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02974-21","article-title":"Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling","volume":"13","author":"Strong","year":"2022","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126720_bb0095","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1099\/mic.0.2008\/019968-0","article-title":"A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins","volume":"154","author":"Singh","year":"2008","journal-title":"Microbiology"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126720_bb0100","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1099\/mic.0.2008\/019968-0","article-title":"A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins","volume":"154","author":"Singh","year":"2008","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126720_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126720_bb0110","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4049\/jimmunol.160.3.1290","article-title":"Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages","volume":"160","author":"Schaible","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126720_bb0115","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1080\/21505594.2020.1785815","article-title":"PE_PGRS proteins of Mycobacterium tuberculosis: a specialized molecular task force at the forefront of host-pathogen interaction","volume":"11","author":"De Maio","year":"2020","journal-title":"Virulence"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126720_bb0120","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1242\/jcs.111.7.897","article-title":"Effects of cytokines on mycobacterial phagosome maturation","volume":"111","author":"Via","year":"1998","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126720_bb0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/imr.12266","article-title":"Macrophage defense mechanisms against intracellular bacteria","volume":"264","author":"Weiss","year":"2015","journal-title":"Immunol Rev"},{"issue":"5645","key":"10.1016\/j.vaccine.2025.126720_bb0130","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1126\/science.1088063","article-title":"Immune control of tuberculosis by IFN-\u03b3-inducible LRG-47","volume":"302","author":"MacMicking","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126720_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157489109789318541","article-title":"Control of mycobacterium tuberculosis infection by glutathione","volume":"4","author":"Connell","year":"2009","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126720_bb0140","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/jcm9092757","article-title":"Understanding the relationship between glutathione, TGF-\u03b2, and vitamin D in combating Mycobacterium tuberculosis infections","volume":"9","author":"Singh","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126720_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02550-18","article-title":"Biphasic dynamics of macrophage Immunometabolism during Mycobacterium tuberculosis infection","volume":"10","author":"Shi","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2025.126720_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2024.102494","article-title":"Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains","volume":"146","author":"Painter","year":"2024","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126720_bb0155","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41598-017-02116-1","article-title":"Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis","volume":"7","author":"Jensen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.126720_bb0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mimet.2016.09.010","article-title":"A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system","volume":"131","author":"Yang","year":"2016","journal-title":"J Microbiol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126720_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0025-2013","article-title":"Mycobacterial Pathogenomics and Evolution","volume":"2","author":"Bottai","year":"2014","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.vaccine.2025.126720_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/srep45258","article-title":"Genomic characterization of nontuberculous mycobacteria","volume":"7","author":"Fedrizzi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.126720_bb0175","article-title":"Comparative genomic analysis reveals differential genomic characteristics and featured genes between rapid- and slow-growing non-tuberculous mycobacteria","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126720_bb0180","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/vaccines11081302","article-title":"Mycobacterium smegmatis, a promising vaccine vector for preventing TB and other diseases: Vaccinomics insights and applications","volume":"11","author":"Xie","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126720_bb0185","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1365-2958.2012.08001.x","article-title":"Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation","volume":"83","author":"Bottai","year":"2012","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126720_bb0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.chom.2008.05.006","article-title":"Mycobacterium tuberculosis and the macrophage: maintaining a balance","volume":"3","author":"Pieters","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126720_bb0195","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220504","article-title":"GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection","volume":"219","author":"Amaral","year":"2022","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126720_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008312","article-title":"TNF-\u03b1 antagonists differentially induce TGF-\u03b21-dependent resuscitation of dormant-like Mycobacterium tuberculosis","volume":"16","author":"Arbu\u00e9s","year":"2020","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126720_bb0205","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1128\/iai.65.11.4843-4849.1997","article-title":"Lethal tuberculosis in interleukin-6-deficient mutant mice","volume":"65","author":"Ladel","year":"1997","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126720_bb0210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4049\/jimmunol.158.1.330","article-title":"IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses","volume":"158","author":"VanHeyningen","year":"1997","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126720_bb0215","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/IAI.68.6.3322-3326.2000","article-title":"Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection","volume":"68","author":"Saunders","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126720_bb0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2018.10.009","article-title":"Regulation of host cell pyroptosis and cytokines production by Mycobacterium tuberculosis effector PPE60 requires LUBAC mediated NF-\u03baB signaling","volume":"335","author":"Gong","year":"2019","journal-title":"Cell Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126720_bb0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10495-016-1249-y","article-title":"Mycobacterium tuberculosis PE13 (Rv1195) manipulates the host cell fate via p38-ERK-NF-\u03baB axis and apoptosis","volume":"21","author":"Li","year":"2016","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0230","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.178.4.1435","article-title":"Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Gu\u00e9rin and subsequent challenge with lipopolysaccharide","volume":"178","author":"Kamijo","year":"1993","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126720_bb0235","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1084\/jem.177.6.1723","article-title":"Mycobacterial virulence. Virulent strains of mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity","volume":"177","author":"North","year":"1993","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0240","doi-asserted-by":"crossref","first-page":"00590","DOI":"10.1183\/23120541.00590-2020","article-title":"Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis","volume":"6","author":"Schuurbiers","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.vaccine.2025.126720_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6473629","article-title":"Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated Mycobacterium abscessus infection","volume":"2018","author":"Chetchotisakd","year":"2018","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10875-022-01423-1","article-title":"Distinct lymphocyte Immunophenotyping and quantitative anti-interferon gamma autoantibodies in Taiwanese HIV-negative patients with non-tuberculous mycobacterial infections","volume":"43","author":"Lee","year":"2023","journal-title":"J Clin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126720_bb0255","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.158.10.4822","article-title":"Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection","volume":"158","author":"Doherty","year":"1997","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126720_bb0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. Tuberculosis infection","volume":"4","year":"2011","journal-title":"Mucosal Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126720_bb0265","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(06)70577-1","article-title":"The two faces of interleukin 10 in human infectious diseases","volume":"6","author":"Mege","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126720_bb0270","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4049\/jimmunol.158.7.3311","article-title":"IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi","volume":"158","author":"Hunter","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126720_bb0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micpath.2018.10.031","article-title":"PPE11 of Mycobacterium tuberculosis can alter host inflammatory response and trigger cell death","volume":"126","author":"Peng","year":"2019","journal-title":"Microb Pathog"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123745","article-title":"Transcriptional profile of Mycobacterium tuberculosis replicating in type II alveolar epithelial cells","volume":"10","author":"Ryndak","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126720_bb0285","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1002\/jcp.27608","article-title":"Expression and regulatory networks of Mycobacterium tuberculosis PE\/PPE family antigens","volume":"234","author":"Li","year":"2019","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126720_bb0290","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1574-6968.2011.02354.x","article-title":"The Rv1651c-encoded PE-PGRS30 protein expressed in Mycobacterium smegmatis exhibits polar localization and modulates its growth profile","volume":"322","author":"Chatrath","year":"2011","journal-title":"FEMS Microbiol Lett"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126720_bb0295","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.micinf.2016.04.004","article-title":"PE_PGRS30 of Mycobacterium tuberculosis mediates suppression of proinflammatory immune response in macrophages through its PGRS and PE domains","volume":"18","author":"Chatrath","year":"2016","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2025.126720_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696491","article-title":"Mycobacterium tuberculosis protein PE6 (Rv0335c), a novel TLR4 agonist, evokes an inflammatory response and modulates the cell death pathways in macrophages to enhance intracellular survival","volume":"12","author":"Sharma","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0305","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.chom.2012.03.003","article-title":"Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential","volume":"11","author":"Sayes","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126720_bb0310","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00284-015-0786-x","article-title":"Identification of Mycobacterium tuberculosis PPE68-specific HLA-A*0201-restricted epitopes for tuberculosis diagnosis","volume":"70","author":"Duan","year":"2015","journal-title":"Curr Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126720_bb0315","first-page":"781","article-title":"Effects of Mycobacterium smegmatis vaccine on cytokines production and Th1\/Th2 responses in mice","volume":"28","author":"Xu","year":"2005","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126720_bb0320","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis","volume":"17","author":"Sweeney","year":"2011","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126720_bb0325","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/vaccines11081302","article-title":"Mycobacterium smegmatis, a promising vaccine vector for preventing TB and other diseases: Vaccinomics insights and applications","volume":"11","author":"Xie","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0330","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1134\/S0026893318040088","article-title":"CTAB-PEG DNA extraction from Fungi with high contents of polysaccharides","volume":"52","author":"Huang","year":"2018","journal-title":"Mol Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126720_bb0335","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/molecules27041247","article-title":"Mammalian cell spheroids on mixed organic-inorganic Superhydrophobic coating","volume":"27","author":"Ferrari","year":"2022","journal-title":"Molecules"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2025.126720_bb0340","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.micpath.2006.04.006","article-title":"Identification of a respiratory-type nitrate reductase and its role for survival of Mycobacterium smegmatis in Wayne model","volume":"41","author":"Khan","year":"2006","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2025.126720_bb0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mimet.2016.09.010","article-title":"A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system","volume":"131","year":"2016","journal-title":"J Microbiol Methods"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126720_bb0350","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tube.2013.04.007","article-title":"Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. Tb)","volume":"93","year":"2013","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126720_bb0355","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1038\/s41598-020-60223-y","article-title":"Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells","volume":"10","author":"Painter","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.126720_bb0360","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41598-017-02116-1","article-title":"Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis","volume":"7","author":"Jensen","year":"2017","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:01:20Z","timestamp":1743876080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":72,"alternative-id":["S0264410X25000179"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126720","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of MMAR_1296 in Mycobacterium marinum and its potential as a vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126720"}}